Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud's Phenomenon Secondary to Connective Tissue Disease”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)Study completedNCT02688270
What this trial is testing

Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon Secondary to Connective Tissue Disease
Covis Pharma S.à.r.l. 65
Testing effectiveness (Phase 2)Study completedNCT04744207
What this trial is testing

Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Gesynta Pharma AB 94
Post-approval studies (Phase 4)Study completedNCT00048763
What this trial is testing

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Otsuka America Pharmaceutical 75
Testing effectiveness (Phase 2)Study completedNCT04388176
What this trial is testing

Cold Challenge With C21 in RP

Who this might be right for
Raynaud PhenomenonSystemic Sclerosis
Vicore Pharma AB 20
Testing effectiveness (Phase 2)Ended earlyNCT04915950
What this trial is testing

Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Pfizer 13
Post-approval studies (Phase 4)Looking for participantsNCT05125029
What this trial is testing

Botulinum Toxin in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
Emory University 36
Large-scale testing (Phase 3)Study completedNCT04040322
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 198
Very early researchStudy completedNCT03027674
What this trial is testing

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Who this might be right for
Raynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more
Pontificia Universidad Catolica de Chile 10
Testing effectiveness (Phase 2)Study completedNCT00707187
What this trial is testing

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Who this might be right for
Systemic Sclerosis
University of Medicine and Dentistry of New Jersey 120
Testing effectiveness (Phase 2)Study completedNCT00378521
What this trial is testing

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease
MediQuest Therapeutics 15
Not applicableUnknownNCT03749577
What this trial is testing

Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 30
Not applicableUnknownNCT01378845
What this trial is testing

Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

Who this might be right for
Raynaud's PhenomenonSkin Necrosis
Christoph Hehrlein 30
Not applicableStudy completedNCT00822354
What this trial is testing

Tadalafil for the Treatment of Raynaud's

Who this might be right for
Raynaud
Northwestern University 10
Testing effectiveness (Phase 2)Ended earlyNCT01315899
What this trial is testing

Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Orion Corporation, Orion Pharma 15
Testing effectiveness (Phase 2)Study completedNCT01926847
What this trial is testing

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

Who this might be right for
Raynaud Disease
Bayer 23
Testing effectiveness (Phase 2)Study completedNCT03867097
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 34
Large-scale testing (Phase 3)UnknownNCT00577304
What this trial is testing

A Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Other Autoimmune Disease
MediQuest Therapeutics 200
Testing effectiveness (Phase 2)Study completedNCT01090492
What this trial is testing

PF-00489791 For The Treatment Of Raynaud's

Who this might be right for
Raynaud's DiseasePeripheral Vascular Disease
Pfizer 243
Not applicableUnknownNCT02183779
What this trial is testing

PORH and Response to Cold in Raynaud's Phenomenon.

Who this might be right for
Raynaud DiseaseHyperemiaCold
University Hospital, Grenoble 60
Large-scale testing (Phase 3)Study completedNCT03717961
What this trial is testing

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 91
Load More Results